IQ EQ Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43M | Buy |
50,840
+6,500
| +15% | +$173K | 0.11% | 170 |
|
|
2025
Q4 | $1.1M | Sell |
44,340
-62,848
| -59% | -$1.58M | 0.08% | 204 |
|
|
2025
Q3 | $2.73M | Sell |
107,188
-1,500
| -1% | -$37K | 0.19% | 134 |
|
|
2025
Q2 | $2.63M | Hold |
108,688
| – | – | 0.23% | 119 |
|
|
2025
Q1 | $2.75M | Sell |
108,688
-149,622
| -58% | -$3.92M | 0.32% | 87 |
|
|
2024
Q4 | $6.85M | Buy |
258,310
+1,850
| +0.7% | +$50.2K | 0.81% | 28 |
|
|
2024
Q3 | $7.42M | Buy |
256,460
+23,928
| +10% | +$698K | 0.77% | 29 |
|
|
2024
Q2 | $6.51M | Sell |
232,532
-500
| -0.2% | -$13.8K | 0.74% | 34 |
|
|
2024
Q1 | $6.47M | Sell |
233,032
-2,100
| -0.9% | -$58.3K | 0.73% | 40 |
|
|
2023
Q4 | $6.77M | Buy |
235,132
+129,225
| +122% | +$3.91M | 0.8% | 28 |
|
|
2023
Q3 | $3.51M | Buy |
105,907
+2,762
| +3% | +$97.7K | 0.72% | 52 |
|
|
2023
Q2 | $3.78M | Buy |
103,145
+1,196
| +1% | +$46.6K | 0.72% | 51 |
|
|
2023
Q1 | $4.16M | Buy |
101,949
+1,768
| +2% | +$76.4K | 0.8% | 46 |
|
|
2022
Q4 | $5.13M | Sell |
100,181
-13,730
| -12% | -$658K | 1.05% | 27 |
|
|
2022
Q3 | $4.99M | Sell |
113,911
-2,678
| -2% | -$130K | 1.12% | 22 |
|
|
2022
Q2 | $6.11M | Buy |
116,589
+603
| +0.5% | +$30.7K | 1.21% | 22 |
|
|
2022
Q1 | $6M | Sell |
115,986
-798
| -0.7% | -$41.4K | 0.98% | 30 |
|
|
2021
Q4 | $6.9M | Sell |
116,784
-7,440
| -6% | -$369K | 1.06% | 27 |
|
|
2021
Q3 | $5.34M | Sell |
124,224
-5,180
| -4% | -$229K | 0.82% | 35 |
|
|
2021
Q2 | $5.07M | Sell |
129,404
-2,735
| -2% | -$106K | 0.78% | 39 |
|
|
2021
Q1 | $4.79M | Buy |
132,139
+3,325
| +3% | +$118K | 0.84% | 24 |
|
|
2020
Q4 | $4.74M | Sell |
128,814
-4,796
| -4% | -$176K | 1.1% | 16 |
|
|
2020
Q3 | $4.65M | Sell |
133,610
-3,799
| -3% | -$133K | 1.39% | 16 |
|
|
2020
Q2 | $4.26M | Sell |
137,409
-805
| -0.6% | -$27.3K | 1.43% | 15 |
|
|
2020
Q1 | $4.28M | Sell |
138,214
-5,032
| -4% | -$171K | 1.75% | 14 |
|
|
2019
Q4 | $5.33M | Sell |
143,246
-2,967
| -2% | -$106K | 1.69% | 13 |
|
|
2019
Q3 | $4.98M | Sell |
146,213
-3,183
| -2% | -$116K | 1.61% | 14 |
|
|
2019
Q2 | $6.14M | Buy |
+149,396
| New | +$5.93M | 1.98% | 10 |
|
|
2018
Q4 | $6.55M | Sell |
158,092
-51,186
| -24% | -$2.12M | 2.4% | 8 |
|
|
2018
Q3 | $9.12M | Sell |
209,278
-84,766
| -29% | -$3.26M | 2.5% | 6 |
|
|
2018
Q2 | $10.1M | Buy |
+294,044
| New | +$10M | 2.71% | 7 |
|
|
2017
Q1 | $16.3M | Sell |
442,962
-9,873
| -2% | -$311K | 3.05% | 13 |
|
|
2016
Q4 | $16M | Buy |
452,835
+2,238
| +0.5% | +$68.3K | 2.91% | 13 |
|
|
2016
Q3 | $15.6M | Buy |
450,597
+12,148
| +3% | +$406K | 2.88% | 11 |
|
|
2016
Q2 | $15.9M | Sell |
438,449
-36,828
| -8% | -$1.18M | 3% | 11 |
|
|
2016
Q1 | $14.2M | Sell |
475,277
-34,785
| -7% | -$994K | 2.59% | 11 |
|
|
2015
Q4 | $17.4M | Sell |
510,062
-218,245
| -30% | -$6.87M | 2.98% | 10 |
|
|
2015
Q3 | $23.5M | Sell |
728,307
-17,713
| -2% | -$568K | 3.8% | 4 |
|
|
2015
Q2 | $25.8M | Buy |
746,020
+83,448
| +13% | +$2.72M | 3.71% | 4 |
|
|
2015
Q1 | $24.6M | Sell |
662,572
-67,823
| -9% | -$2.16M | 3.3% | 9 |
|
|
2014
Q4 | $21.6M | Buy |
+730,395
| New | +$20.9M | 3.13% | 10 |
|
Other funds holding PFE
VCM
VPM
IQ EQ Fund Management's PFE Position: Q1 2026 in Review
IQ EQ Fund Management increased its Pfizer (PFE) stake by 15% in Q1 2026, buying an estimated $173K and bringing the position to 50,840 shares worth $1.43M. The position accounts for 0.11% of the portfolio, ranked #170.
IQ EQ Fund Management first reported a position in PFE in Q4 2014 and has held it in 41 quarters since. The position peaked at $25.8M in Q2 2015. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- IQ EQ Fund Management held 50,840 shares of Pfizer worth $1.43M as of Q1 2026.
- IQ EQ Fund Management bought 6,500 Pfizer shares in Q1 2026, an estimated $173K.
- Pfizer made up 0.11% of IQ EQ Fund Management's portfolio in Q1 2026, its #170 holding.
- IQ EQ Fund Management first reported a position in Pfizer in Q4 2014 and has held it in 41 quarters since.
- IQ EQ Fund Management's Pfizer position peaked at $25.8M in Q2 2015.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.